Key Nontuberculous Mycobacterium Treatment Market Players:
- Insmed
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer
- AbbVie
- Paratek Therapeutics
- Viatris (Mylan/Upjohn)
- Sandoz (Novartis)
- Teva Pharmaceuticals
- Cipla
- Dr. Reddy’s Laboratories
- Sun Pharmaceutical Industries
- Fresenius Kabi
- Hikma Pharmaceuticals
- Sagent Pharmaceuticals
- Amneal Pharmaceuticals
- Baxter (Injectables Division)
- Shionogi
- Takeda
- Daiichi Sankyo
- Otsuka Pharmaceutical
- Astellas Pharma
The global marketplace in which nontuberculous mycobacterium operates under strong competitive forces. The industry leaders actively focus in developing new antibiotics and biologics through substantial research investments to address resistant NTM strains. Their business approach includes establishing biotech partnerships while acquiring new products and exploring Indian and Southeast Asian emerging markets. The market participants pursue partnerships with medical institutions and regulatory bodies to speed up drug approvals while expanding their international market presence.
Below is the list of some prominent players operating in the market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Nontuberculous mycobacterium treatment market size was valued at USD 9.8 billion in 2025.
Nontuberculous mycobacterium treatment market size was valued at USD 9.8 billion in 2025 and is projected to reach USD 12.8 billion by the end of 2035, rising at a CAGR of 2.8 % during the forecast period, i.e., 2026 2035.
North America is anticipated to capture the highest share of 39% in the global nontuberculous mycobacterium treatment market by the end of 2035.
The major players in the market are Insmed, Pfizer, AbbVie, Paratek Therapeutics, Viatris (Mylan/Upjohn), Sandoz (Novartis), Teva Pharmaceuticals, Cipla, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Fresenius Kabi, Hikma Pharmaceuticals, Sagent Pharmaceuticals, Amneal Pharmaceuticals, Baxter (Injectables Division), Shionogi, Takeda, Daiichi Sankyo, Otsuka Pharmaceutical, Astellas Pharma.
